Welcome to the
Sugarbaker Oncology Associates Home Page

 

 

Paul H. Sugarbaker, MD, FACS, FRCS

 

 



We are the Center for Surgical Oncology at the Washington Cancer Institute, Washington Hospital Center, in Washington, D.C. We specialize in the surgical treatment of cancers that arise in the gastrointestinal tract (appendix cancer, colon cancer, and rectal cancer); and other areas of the abdomen and pelvis.

Our advanced services include specialty treatment programs for pseudomyxoma peritonei, peritoneal carcinomatosis (cancers that have spread to the intraabdominal surfaces), as well as primary peritoneal surface malignancies such as peritoneal mesothelioma.



 

 

UPCOMING EVENTS:

7th International Workshop on Peritoneal Surface Malignancy

Uppsala, Sweden

September 8-10, 2010

www.peritonealconference2010.com

 

New and recent medical articles/journals authored or co-authored by Dr. Sugarbaker:

1.      Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, Rai SN. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010 Jan;20(1):61-9.

2.      Sugarbaker PH. Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol. 2010 Mar 1;101(3):251-2.

3.      Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009 Dec 20;27(36):6237-42. Epub 2009 Nov 16.

4.      Zappa L, Godwin TA, Sugarbaker PH. Tailgut cyst, an unusual cause of pseudomyxoma peritonei. Tumori. 2009 Jul-Aug;95(4):514-7.

5.      Sugarbaker PH. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Expert Opin Pharmacother. 2009 Aug;10(12):1965-77.

6.      Sugarbaker PH. Epithelial appendiceal neoplasms. Cancer J. 2009 May-Jun;15(3):225-35. Review. PubMed PMID: 19556909.

7.      Van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J. 2009 May-Jun;15(3):216-24.

8.      Sugarbaker PH. From the guest editors: introduction: progress in the management of carcinomatosis. Cancer J. 2009 May-Jun;15(3):182-3.

9.      Kamath A, Yoo D, Stuart OA, Bijelic L, Sugarbaker PH. Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. Recent Pat Anticancer Drug Discov. 2009 Jun;4(2):174-9. Review. PubMed PMID: 19519540.

10.  Haase E, Yoo D, Sugarbaker PH. Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol. 2009 May 19;7:48.

11.  Van der Speeten K, Stuart OA, Sugarbaker PH. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol. 2009 Mar;6(1):72-81.

12.  Zappa L, Savady R, Humphries GN, Sugarbaker PH. Interstitial pneumonitis following intrapleural chemotherapy. World J Surg Oncol. 2009 Feb 12;7:17.

13.  Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer. Curr Opin Obstet Gynecol. 2009 Feb;21(1):15-24.
 

Check out our web publications!

Management of Peritoneal Surface Malignancy Using
Intraperitoneal Chemotherapy and Cytoreductive Surgery:
A Manual for Physicians and Nurses

Atlas of Appendix Cancer and Pseudomyxoma Peritonei

Management of Peritoneal Surface Malignancy:
Appendix Cancer and Pseudomyxoma Peritonei, Colon Cancer, and Primary Peritoneal Malignancy

Hyperthermic Intraoperative Intraperitoneal Chemotherapy Tutorial

Protocol for the Implementation of Treatment of Patients with Peritoneal Surface Malignancy with Hyperthermic Intraoperative Intraperitoneal Chemotherapy and Normothermic Early Postoperative Intraperitoneal Chemotherapy

Technical Handbook for the Integration of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy into the Surgical Management of Gastrointestinal and Gynecologic Malignancy



We are pleased to introduce our list of international colleagues.




Introduction to SOAIntroduction to SOA

Introduction to SOAQuick Tour of Our Web Site

Introduction to SOAQuick Tour of Washington Hospital Center

Introduction to SOAResources for Patients and Families

Introduction to SOAResources for Medical Professionals

Introduction to SOAFARGO

Introduction to SOAYour Surgery & Hospitalization: What to Expect



Please contact us at:

Sugarbaker Oncology Associates
Washington Hospital Center
106 Irving St., NW, Suite 3900
Washington, D.C. 20010

Phone 202-877-3908
Fax 202-877-8602

You are visitor number
Hit Counter

Copyright 1996
Sugarbaker Oncology Associates
Washington Hospital Center
106 Irving St., NW, Suite 3900N
Washington, D.C. 20010

All Rights Reserved


Last Revised 3/13/2010